| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Barrett Esophagus | 39 | 2024 | 494 | 3.120 |
Why?
|
| Esophageal Neoplasms | 38 | 2024 | 1676 | 1.890 |
Why?
|
| Esophagus | 27 | 2018 | 1045 | 1.590 |
Why?
|
| Esophagoscopy | 21 | 2024 | 398 | 1.210 |
Why?
|
| Spectrometry, Fluorescence | 8 | 2008 | 694 | 1.000 |
Why?
|
| Precancerous Conditions | 18 | 2016 | 988 | 0.970 |
Why?
|
| Photochemotherapy | 16 | 2011 | 832 | 0.970 |
Why?
|
| Laser Therapy | 25 | 2014 | 1107 | 0.870 |
Why?
|
| Lasers | 18 | 2009 | 952 | 0.750 |
Why?
|
| Adenocarcinoma | 25 | 2024 | 6400 | 0.690 |
Why?
|
| Computer Terminals | 1 | 2019 | 41 | 0.650 |
Why?
|
| Colonic Polyps | 4 | 2019 | 557 | 0.650 |
Why?
|
| Endoscopy, Gastrointestinal | 8 | 2012 | 887 | 0.620 |
Why?
|
| Dihematoporphyrin Ether | 8 | 2011 | 33 | 0.600 |
Why?
|
| Tomography | 6 | 2003 | 442 | 0.590 |
Why?
|
| Colonoscopy | 5 | 2019 | 1412 | 0.550 |
Why?
|
| Microscopy, Confocal | 8 | 2018 | 1977 | 0.550 |
Why?
|
| Adenoma | 5 | 2020 | 2163 | 0.500 |
Why?
|
| Photosensitizing Agents | 5 | 2011 | 633 | 0.450 |
Why?
|
| Gastric Mucosa | 8 | 2018 | 603 | 0.440 |
Why?
|
| Microscopy, Interference | 2 | 2003 | 35 | 0.430 |
Why?
|
| Endoscopes, Gastrointestinal | 2 | 2005 | 45 | 0.420 |
Why?
|
| Tomography, Optical | 2 | 2003 | 129 | 0.400 |
Why?
|
| Tomography, Optical Coherence | 10 | 2021 | 2958 | 0.390 |
Why?
|
| Connective Tissue | 4 | 2003 | 425 | 0.390 |
Why?
|
| Cholelithiasis | 7 | 1992 | 408 | 0.370 |
Why?
|
| Lithotripsy | 6 | 1992 | 141 | 0.350 |
Why?
|
| Indocyanine Green | 3 | 1999 | 239 | 0.350 |
Why?
|
| Light Coagulation | 5 | 1991 | 72 | 0.340 |
Why?
|
| Capsule Endoscopy | 3 | 2018 | 106 | 0.340 |
Why?
|
| Aminolevulinic Acid | 2 | 2002 | 150 | 0.330 |
Why?
|
| Intestinal Neoplasms | 3 | 2008 | 317 | 0.310 |
Why?
|
| Endoscopy, Digestive System | 8 | 2018 | 354 | 0.300 |
Why?
|
| Gastrointestinal Diseases | 4 | 2013 | 1207 | 0.290 |
Why?
|
| Colonic Neoplasms | 2 | 2019 | 2544 | 0.290 |
Why?
|
| Metaplasia | 4 | 2024 | 326 | 0.290 |
Why?
|
| Phototherapy | 2 | 2008 | 369 | 0.290 |
Why?
|
| Esophageal Stenosis | 2 | 2010 | 197 | 0.280 |
Why?
|
| Equipment Design | 10 | 2019 | 3530 | 0.280 |
Why?
|
| Lithotripsy, Laser | 4 | 1992 | 45 | 0.270 |
Why?
|
| Coloring Agents | 3 | 1999 | 564 | 0.270 |
Why?
|
| Protoporphyrins | 2 | 2008 | 170 | 0.270 |
Why?
|
| Burns | 8 | 1999 | 1887 | 0.270 |
Why?
|
| Upper Gastrointestinal Tract | 2 | 2018 | 46 | 0.260 |
Why?
|
| Bile Ducts, Intrahepatic | 3 | 2002 | 304 | 0.230 |
Why?
|
| Fiber Optic Technology | 3 | 2017 | 291 | 0.230 |
Why?
|
| Nitrogen | 2 | 2024 | 345 | 0.230 |
Why?
|
| Microscopy | 5 | 2013 | 909 | 0.230 |
Why?
|
| Intestinal Mucosa | 6 | 2018 | 3048 | 0.220 |
Why?
|
| Optics and Photonics | 3 | 2003 | 307 | 0.220 |
Why?
|
| Endoscopy | 6 | 2017 | 1857 | 0.200 |
Why?
|
| Image Enhancement | 4 | 2009 | 2894 | 0.200 |
Why?
|
| Aspirin | 4 | 2020 | 3139 | 0.200 |
Why?
|
| Spectrum Analysis | 3 | 2003 | 450 | 0.200 |
Why?
|
| Endoscopes | 3 | 1999 | 169 | 0.200 |
Why?
|
| Eosinophilic Esophagitis | 2 | 2018 | 204 | 0.190 |
Why?
|
| Microsatellite Repeats | 2 | 2001 | 784 | 0.190 |
Why?
|
| Cryotherapy | 2 | 2024 | 160 | 0.190 |
Why?
|
| Adenocarcinoma, Scirrhous | 1 | 2001 | 5 | 0.190 |
Why?
|
| Swine | 20 | 2009 | 5996 | 0.180 |
Why?
|
| Esophageal Diseases | 2 | 2010 | 168 | 0.180 |
Why?
|
| Holmium | 5 | 1996 | 29 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2001 | 247 | 0.180 |
Why?
|
| Anticarcinogenic Agents | 2 | 2017 | 251 | 0.170 |
Why?
|
| Digestive System | 1 | 2000 | 244 | 0.170 |
Why?
|
| Loss of Heterozygosity | 2 | 2001 | 663 | 0.160 |
Why?
|
| Gastrointestinal Tract | 2 | 2017 | 840 | 0.160 |
Why?
|
| Cryosurgery | 3 | 2024 | 477 | 0.160 |
Why?
|
| Feasibility Studies | 12 | 2021 | 5308 | 0.160 |
Why?
|
| Stomach Diseases | 1 | 2000 | 134 | 0.160 |
Why?
|
| Sensitivity and Specificity | 13 | 2018 | 14728 | 0.160 |
Why?
|
| Bile Duct Neoplasms | 3 | 2002 | 617 | 0.150 |
Why?
|
| Intestinal Polyps | 3 | 2008 | 105 | 0.150 |
Why?
|
| Stomach | 3 | 2018 | 703 | 0.150 |
Why?
|
| Aged | 47 | 2024 | 171520 | 0.150 |
Why?
|
| Adenomatous Polyps | 1 | 1998 | 109 | 0.150 |
Why?
|
| Gallstones | 2 | 1992 | 285 | 0.140 |
Why?
|
| Biopsy | 14 | 2021 | 6816 | 0.140 |
Why?
|
| Dinoprostone | 1 | 2020 | 597 | 0.140 |
Why?
|
| Mucous Membrane | 5 | 2011 | 660 | 0.140 |
Why?
|
| Scattering, Radiation | 6 | 2003 | 491 | 0.140 |
Why?
|
| Pilot Projects | 13 | 2018 | 8730 | 0.140 |
Why?
|
| Catheter Ablation | 3 | 2017 | 2775 | 0.140 |
Why?
|
| Population Surveillance | 3 | 2009 | 2601 | 0.140 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2001 | 1064 | 0.130 |
Why?
|
| Humans | 104 | 2024 | 768451 | 0.130 |
Why?
|
| Male | 67 | 2024 | 364781 | 0.130 |
Why?
|
| Colon | 4 | 1998 | 1804 | 0.120 |
Why?
|
| Female | 68 | 2024 | 396943 | 0.120 |
Why?
|
| Light | 3 | 2005 | 1357 | 0.120 |
Why?
|
| Middle Aged | 48 | 2024 | 223418 | 0.120 |
Why?
|
| Stomach Neoplasms | 2 | 2006 | 1484 | 0.120 |
Why?
|
| Biopsy, Needle | 3 | 2016 | 1629 | 0.120 |
Why?
|
| Absorption | 3 | 2003 | 243 | 0.110 |
Why?
|
| Mass Screening | 2 | 2009 | 5455 | 0.110 |
Why?
|
| Cholangiocarcinoma | 2 | 2002 | 563 | 0.110 |
Why?
|
| Photometry | 1 | 2013 | 57 | 0.110 |
Why?
|
| Cystic Duct | 1 | 1992 | 18 | 0.110 |
Why?
|
| Helicobacter pylori | 2 | 2008 | 382 | 0.110 |
Why?
|
| Helicobacter Infections | 2 | 2008 | 392 | 0.100 |
Why?
|
| Infrared Rays | 5 | 2003 | 249 | 0.100 |
Why?
|
| Aged, 80 and over | 23 | 2020 | 59680 | 0.100 |
Why?
|
| Gastroesophageal Reflux | 3 | 2010 | 833 | 0.100 |
Why?
|
| Skin | 9 | 1998 | 4520 | 0.100 |
Why?
|
| Fluorometry | 1 | 1992 | 99 | 0.100 |
Why?
|
| Gastrointestinal Hemorrhage | 3 | 2010 | 1126 | 0.100 |
Why?
|
| Acoustics | 2 | 2003 | 244 | 0.100 |
Why?
|
| Urinary Calculi | 2 | 1989 | 90 | 0.090 |
Why?
|
| Laparoscopes | 1 | 1991 | 37 | 0.090 |
Why?
|
| Sulfasalazine | 1 | 1991 | 85 | 0.090 |
Why?
|
| Gastroenterology | 1 | 2017 | 588 | 0.090 |
Why?
|
| Decision Support Techniques | 3 | 2017 | 2010 | 0.090 |
Why?
|
| Elasticity | 2 | 2003 | 658 | 0.090 |
Why?
|
| Cell Degranulation | 1 | 2011 | 277 | 0.090 |
Why?
|
| Equipment Failure Analysis | 2 | 2003 | 848 | 0.090 |
Why?
|
| Laser Coagulation | 1 | 1992 | 333 | 0.090 |
Why?
|
| Omeprazole | 2 | 2008 | 106 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2279 | 0.090 |
Why?
|
| Obstetric Labor, Premature | 1 | 2012 | 273 | 0.090 |
Why?
|
| Epithelium | 4 | 2011 | 1610 | 0.090 |
Why?
|
| Smoking | 6 | 2010 | 9099 | 0.090 |
Why?
|
| Nasal Bone | 1 | 1990 | 58 | 0.090 |
Why?
|
| Endometrium | 1 | 1992 | 407 | 0.090 |
Why?
|
| Rabbits | 8 | 1998 | 4786 | 0.080 |
Why?
|
| Electrocoagulation | 2 | 2006 | 153 | 0.080 |
Why?
|
| Pancreas | 4 | 2006 | 1703 | 0.080 |
Why?
|
| Health Education | 1 | 1996 | 1059 | 0.080 |
Why?
|
| Herpesvirus 1, Equid | 1 | 1989 | 1 | 0.080 |
Why?
|
| Animals | 41 | 2009 | 169418 | 0.080 |
Why?
|
| Monte Carlo Method | 3 | 2004 | 1262 | 0.080 |
Why?
|
| Oxyhemoglobins | 3 | 1999 | 213 | 0.080 |
Why?
|
| Cyclooxygenase 2 | 1 | 2011 | 599 | 0.080 |
Why?
|
| Fluorescence | 4 | 1999 | 760 | 0.080 |
Why?
|
| Colorectal Neoplasms | 2 | 2020 | 6978 | 0.080 |
Why?
|
| Sulfonamides | 2 | 2008 | 1988 | 0.080 |
Why?
|
| Herpesviridae | 1 | 1989 | 104 | 0.080 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 1992 | 484 | 0.080 |
Why?
|
| Treatment Outcome | 17 | 2024 | 65409 | 0.080 |
Why?
|
| Prospective Studies | 10 | 2024 | 54914 | 0.080 |
Why?
|
| Hematoporphyrin Photoradiation | 1 | 2007 | 17 | 0.070 |
Why?
|
| Antigens, Viral | 2 | 1989 | 992 | 0.070 |
Why?
|
| Abscess | 1 | 2011 | 607 | 0.070 |
Why?
|
| Recovery of Function | 1 | 2018 | 2994 | 0.070 |
Why?
|
| Markov Chains | 3 | 2012 | 977 | 0.070 |
Why?
|
| Pathology, Surgical | 1 | 2009 | 151 | 0.070 |
Why?
|
| Pyrazoles | 2 | 2008 | 2024 | 0.070 |
Why?
|
| Phantoms, Imaging | 3 | 2013 | 2528 | 0.070 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 1987 | 47 | 0.070 |
Why?
|
| Registries | 1 | 2024 | 8373 | 0.070 |
Why?
|
| Chi-Square Distribution | 4 | 2018 | 3438 | 0.070 |
Why?
|
| Behcet Syndrome | 1 | 2008 | 86 | 0.070 |
Why?
|
| Time Factors | 14 | 2018 | 40271 | 0.070 |
Why?
|
| Pathology | 1 | 2010 | 270 | 0.070 |
Why?
|
| Polymorphism, Genetic | 2 | 2008 | 4249 | 0.070 |
Why?
|
| Adult | 23 | 2024 | 223542 | 0.070 |
Why?
|
| Liver | 4 | 2004 | 7575 | 0.070 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 1 | 2007 | 106 | 0.070 |
Why?
|
| Maxilla | 1 | 1990 | 489 | 0.070 |
Why?
|
| Anti-Ulcer Agents | 1 | 2007 | 112 | 0.070 |
Why?
|
| Eosinophils | 1 | 2011 | 955 | 0.070 |
Why?
|
| Surgical Procedures, Operative | 1 | 2017 | 1937 | 0.060 |
Why?
|
| Health Care Costs | 2 | 2012 | 3265 | 0.060 |
Why?
|
| Physical Exertion | 2 | 1999 | 669 | 0.060 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 462 | 0.060 |
Why?
|
| Defective Viruses | 1 | 1985 | 89 | 0.060 |
Why?
|
| Carcinoma | 1 | 2017 | 2341 | 0.060 |
Why?
|
| Epidermal Growth Factor | 1 | 2008 | 699 | 0.060 |
Why?
|
| Sickness Impact Profile | 1 | 2006 | 299 | 0.060 |
Why?
|
| Debridement | 2 | 1998 | 494 | 0.060 |
Why?
|
| Ultraviolet Rays | 4 | 1995 | 1100 | 0.060 |
Why?
|
| Diagnosis, Differential | 5 | 2016 | 13026 | 0.060 |
Why?
|
| Neoplasm, Residual | 1 | 2010 | 1014 | 0.060 |
Why?
|
| Hepatitis, Viral, Human | 1 | 1985 | 141 | 0.060 |
Why?
|
| Models, Biological | 4 | 2013 | 9505 | 0.060 |
Why?
|
| Intestines | 2 | 2013 | 1912 | 0.060 |
Why?
|
| Osteotomy | 1 | 1990 | 838 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2013 | 4077 | 0.060 |
Why?
|
| Patient Satisfaction | 2 | 2008 | 3484 | 0.060 |
Why?
|
| Health Promotion | 1 | 1996 | 2215 | 0.060 |
Why?
|
| Diagnostic Imaging | 2 | 2009 | 3543 | 0.060 |
Why?
|
| Forecasting | 3 | 2003 | 2950 | 0.060 |
Why?
|
| Urinary Bladder | 1 | 1990 | 1160 | 0.060 |
Why?
|
| Cholestasis | 1 | 1987 | 385 | 0.050 |
Why?
|
| Research Design | 2 | 2017 | 6217 | 0.050 |
Why?
|
| Esophagectomy | 4 | 2009 | 482 | 0.050 |
Why?
|
| Odds Ratio | 3 | 2012 | 9687 | 0.050 |
Why?
|
| Follow-Up Studies | 10 | 2014 | 39430 | 0.050 |
Why?
|
| Optical Fibers | 1 | 2002 | 135 | 0.050 |
Why?
|
| Factor Analysis, Statistical | 2 | 2018 | 1007 | 0.050 |
Why?
|
| Spectrophotometry, Infrared | 2 | 1999 | 117 | 0.050 |
Why?
|
| Photobiology | 1 | 2001 | 10 | 0.050 |
Why?
|
| Retrospective Studies | 11 | 2017 | 81834 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2010 | 9066 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2010 | 16029 | 0.050 |
Why?
|
| Neoplasm Staging | 4 | 2010 | 11249 | 0.050 |
Why?
|
| Models, Theoretical | 3 | 2018 | 3590 | 0.050 |
Why?
|
| Heart Valve Diseases | 1 | 1989 | 1033 | 0.050 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2017 | 1734 | 0.050 |
Why?
|
| Skin Transplantation | 2 | 1998 | 1097 | 0.040 |
Why?
|
| Forearm | 1 | 2003 | 428 | 0.040 |
Why?
|
| Bile Ducts | 1 | 2002 | 288 | 0.040 |
Why?
|
| Carbon Dioxide | 4 | 1998 | 1152 | 0.040 |
Why?
|
| Arthritis, Rheumatoid | 2 | 1998 | 3763 | 0.040 |
Why?
|
| Mitral Valve | 1 | 1989 | 1473 | 0.040 |
Why?
|
| Observer Variation | 3 | 2013 | 2622 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 3 | 1998 | 2640 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 5 | 2017 | 5532 | 0.040 |
Why?
|
| Calcinosis | 1 | 1989 | 1485 | 0.040 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2000 | 105 | 0.040 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2000 | 139 | 0.040 |
Why?
|
| Prostheses and Implants | 1 | 1987 | 1279 | 0.040 |
Why?
|
| Hemoglobins | 4 | 1999 | 1532 | 0.040 |
Why?
|
| Endosonography | 1 | 2004 | 622 | 0.040 |
Why?
|
| Hepatitis B | 1 | 1985 | 707 | 0.040 |
Why?
|
| Rats | 7 | 2008 | 23839 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2010 | 18048 | 0.040 |
Why?
|
| Motion | 1 | 2003 | 788 | 0.040 |
Why?
|
| Algorithms | 5 | 2013 | 14158 | 0.040 |
Why?
|
| Japan | 4 | 1999 | 1418 | 0.040 |
Why?
|
| Colonoscopes | 1 | 1998 | 17 | 0.040 |
Why?
|
| Sampling Studies | 2 | 2016 | 617 | 0.040 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2002 | 515 | 0.040 |
Why?
|
| Aortic Valve | 1 | 1989 | 1968 | 0.040 |
Why?
|
| Meperidine | 1 | 2018 | 38 | 0.040 |
Why?
|
| Myocardium | 1 | 1992 | 4788 | 0.040 |
Why?
|
| Respiratory Muscles | 1 | 1999 | 144 | 0.040 |
Why?
|
| Logistic Models | 4 | 2014 | 13324 | 0.040 |
Why?
|
| Double-Blind Method | 3 | 2020 | 12450 | 0.040 |
Why?
|
| Incidence | 3 | 2017 | 21552 | 0.040 |
Why?
|
| Antibodies, Viral | 2 | 1989 | 3212 | 0.040 |
Why?
|
| Hyperplasia | 4 | 2011 | 1154 | 0.040 |
Why?
|
| Cartilage, Articular | 3 | 1998 | 1104 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2014 | 9425 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2007 | 8559 | 0.040 |
Why?
|
| Adolescent Behavior | 2 | 1999 | 1192 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 3520 | 0.040 |
Why?
|
| Aerosols | 2 | 2010 | 637 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2003 | 1112 | 0.040 |
Why?
|
| Common Bile Duct | 2 | 1988 | 106 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2010 | 4083 | 0.030 |
Why?
|
| Linear Models | 2 | 2018 | 5880 | 0.030 |
Why?
|
| Reproducibility of Results | 6 | 2009 | 20231 | 0.030 |
Why?
|
| Monitoring, Physiologic | 2 | 2016 | 1795 | 0.030 |
Why?
|
| Dyspepsia | 2 | 2009 | 116 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2008 | 361 | 0.030 |
Why?
|
| Calibration | 1 | 1999 | 823 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 1999 | 661 | 0.030 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2000 | 595 | 0.030 |
Why?
|
| Immersion | 1 | 1996 | 37 | 0.030 |
Why?
|
| Prostaglandins | 1 | 2017 | 398 | 0.030 |
Why?
|
| Air | 1 | 1996 | 187 | 0.030 |
Why?
|
| Hemostasis, Surgical | 1 | 1996 | 127 | 0.030 |
Why?
|
| Cholangiography | 2 | 1992 | 182 | 0.030 |
Why?
|
| Body Mass Index | 2 | 2010 | 13030 | 0.030 |
Why?
|
| Duodenum | 1 | 2018 | 495 | 0.030 |
Why?
|
| Obesity, Morbid | 1 | 2006 | 1309 | 0.030 |
Why?
|
| Fentanyl | 1 | 2018 | 450 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 1995 | 882 | 0.030 |
Why?
|
| Skin Physiological Phenomena | 1 | 1995 | 194 | 0.030 |
Why?
|
| Barium Sulfate | 1 | 1995 | 180 | 0.030 |
Why?
|
| Synovial Membrane | 1 | 1998 | 536 | 0.030 |
Why?
|
| Computer Simulation | 2 | 2012 | 6278 | 0.030 |
Why?
|
| Disease Progression | 4 | 2017 | 13655 | 0.030 |
Why?
|
| Sigmoidoscopy | 1 | 1995 | 151 | 0.030 |
Why?
|
| Enema | 1 | 1995 | 141 | 0.030 |
Why?
|
| Medical Staff, Hospital | 1 | 2018 | 603 | 0.030 |
Why?
|
| Risk Factors | 9 | 2017 | 74915 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2007 | 3408 | 0.030 |
Why?
|
| Apoptosis | 1 | 2010 | 9526 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 8635 | 0.030 |
Why?
|
| Leg | 1 | 1999 | 1089 | 0.030 |
Why?
|
| Chickens | 1 | 1996 | 860 | 0.030 |
Why?
|
| Sodium Chloride | 1 | 1996 | 585 | 0.030 |
Why?
|
| Regression Analysis | 3 | 2018 | 6353 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 1409 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1997 | 2298 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2008 | 10784 | 0.030 |
Why?
|
| Self Concept | 1 | 1999 | 1050 | 0.030 |
Why?
|
| Multivariate Analysis | 3 | 2018 | 12096 | 0.030 |
Why?
|
| Case-Control Studies | 5 | 2010 | 22293 | 0.030 |
Why?
|
| Video Recording | 1 | 1998 | 974 | 0.030 |
Why?
|
| Hot Temperature | 2 | 1998 | 1439 | 0.030 |
Why?
|
| Cholecystostomy | 1 | 1992 | 49 | 0.030 |
Why?
|
| Hernia, Hiatal | 1 | 2014 | 90 | 0.030 |
Why?
|
| Biophysical Phenomena | 2 | 1996 | 321 | 0.030 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2000 | 959 | 0.030 |
Why?
|
| Ritodrine | 1 | 2012 | 4 | 0.030 |
Why?
|
| Single-Blind Method | 2 | 2007 | 1585 | 0.030 |
Why?
|
| Tendon Injuries | 1 | 1996 | 329 | 0.030 |
Why?
|
| Cattle | 4 | 1995 | 3830 | 0.030 |
Why?
|
| Tocolysis | 1 | 2012 | 18 | 0.030 |
Why?
|
| Rats, Nude | 1 | 1992 | 106 | 0.020 |
Why?
|
| Tocolytic Agents | 1 | 2012 | 24 | 0.020 |
Why?
|
| Biophysics | 2 | 1996 | 379 | 0.020 |
Why?
|
| Models, Animal | 2 | 2009 | 2126 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 1989 | 9263 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2012 | 224 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2007 | 9623 | 0.020 |
Why?
|
| Tendons | 1 | 1996 | 559 | 0.020 |
Why?
|
| Palliative Care | 1 | 1987 | 3644 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 4 | 1996 | 1629 | 0.020 |
Why?
|
| Glycogen | 1 | 1992 | 252 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2017 | 1444 | 0.020 |
Why?
|
| Quality of Life | 2 | 2017 | 13497 | 0.020 |
Why?
|
| NAD | 2 | 1992 | 618 | 0.020 |
Why?
|
| Cohort Studies | 5 | 2018 | 41797 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2014 | 6537 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1992 | 2087 | 0.020 |
Why?
|
| Wound Healing | 4 | 1998 | 2819 | 0.020 |
Why?
|
| Myocardial Reperfusion | 1 | 1992 | 339 | 0.020 |
Why?
|
| Prognosis | 2 | 2008 | 30028 | 0.020 |
Why?
|
| Radiation Dosage | 2 | 1989 | 1973 | 0.020 |
Why?
|
| Severity of Illness Index | 4 | 2012 | 15965 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 1996 | 2932 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2017 | 10125 | 0.020 |
Why?
|
| Neutralization Tests | 2 | 1989 | 740 | 0.020 |
Why?
|
| Ventricular Function | 1 | 1992 | 406 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 11138 | 0.020 |
Why?
|
| Intestine, Small | 1 | 1996 | 1218 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1992 | 1379 | 0.020 |
Why?
|
| Thermodynamics | 3 | 1996 | 594 | 0.020 |
Why?
|
| Angiography | 1 | 1995 | 1598 | 0.020 |
Why?
|
| Pestivirus | 1 | 1989 | 2 | 0.020 |
Why?
|
| Bovine Virus Diarrhea-Mucosal Disease | 1 | 1989 | 4 | 0.020 |
Why?
|
| Diarrhea Viruses, Bovine Viral | 1 | 1989 | 6 | 0.020 |
Why?
|
| Cardiac Output | 1 | 1992 | 838 | 0.020 |
Why?
|
| Disease Models, Animal | 5 | 2004 | 18388 | 0.020 |
Why?
|
| Cattle Diseases | 1 | 1989 | 50 | 0.020 |
Why?
|
| Young Adult | 4 | 2020 | 60045 | 0.020 |
Why?
|
| Cholecystectomy | 1 | 1991 | 409 | 0.020 |
Why?
|
| Photobleaching | 1 | 2008 | 29 | 0.020 |
Why?
|
| Diverticulum | 1 | 1989 | 137 | 0.020 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2008 | 44 | 0.020 |
Why?
|
| Postoperative Complications | 2 | 2010 | 15880 | 0.020 |
Why?
|
| Ciliary Body | 1 | 1989 | 168 | 0.020 |
Why?
|
| Phosphates | 1 | 1992 | 767 | 0.020 |
Why?
|
| Precipitin Tests | 1 | 1989 | 816 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 1892 | 0.020 |
Why?
|
| Models, Economic | 1 | 2012 | 717 | 0.020 |
Why?
|
| Age Factors | 3 | 2008 | 18478 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 2008 | 363 | 0.020 |
Why?
|
| Hybridomas | 1 | 1989 | 444 | 0.020 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2008 | 146 | 0.020 |
Why?
|
| Physical Phenomena | 1 | 1987 | 48 | 0.020 |
Why?
|
| Adolescent | 7 | 2020 | 89168 | 0.020 |
Why?
|
| Pancreatitis | 1 | 1994 | 1087 | 0.020 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2008 | 138 | 0.020 |
Why?
|
| Sclera | 1 | 1989 | 190 | 0.020 |
Why?
|
| Cell Count | 1 | 2011 | 1835 | 0.020 |
Why?
|
| Esophagogastric Junction | 1 | 2009 | 349 | 0.020 |
Why?
|
| Herpesviridae Infections | 1 | 1989 | 269 | 0.020 |
Why?
|
| Recurrence | 2 | 2006 | 8510 | 0.020 |
Why?
|
| Physics | 1 | 1987 | 93 | 0.020 |
Why?
|
| Colonic Diseases | 1 | 1988 | 203 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2010 | 993 | 0.020 |
Why?
|
| Cost Savings | 1 | 2012 | 916 | 0.020 |
Why?
|
| Cardia | 1 | 2006 | 61 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 1989 | 621 | 0.020 |
Why?
|
| Chemoprevention | 1 | 2008 | 326 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2004 | 5442 | 0.020 |
Why?
|
| Hypertension | 1 | 2006 | 8611 | 0.020 |
Why?
|
| Necrosis | 3 | 1998 | 1621 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 1992 | 1617 | 0.020 |
Why?
|
| Therapeutic Irrigation | 1 | 1987 | 297 | 0.020 |
Why?
|
| Cricetinae | 1 | 1989 | 2423 | 0.020 |
Why?
|
| Pyloric Antrum | 1 | 2005 | 66 | 0.020 |
Why?
|
| Oxygen | 2 | 1998 | 4269 | 0.010 |
Why?
|
| Risk Assessment | 3 | 2017 | 24311 | 0.010 |
Why?
|
| Lymph Node Excision | 1 | 1991 | 1276 | 0.010 |
Why?
|
| Hospitals, Urban | 1 | 2006 | 501 | 0.010 |
Why?
|
| Acute Disease | 1 | 1995 | 7246 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 1994 | 2705 | 0.010 |
Why?
|
| Angioplasty | 1 | 2006 | 357 | 0.010 |
Why?
|
| Aorta | 1 | 1992 | 2046 | 0.010 |
Why?
|
| Massachusetts | 2 | 2009 | 8908 | 0.010 |
Why?
|
| Boston | 1 | 2017 | 9361 | 0.010 |
Why?
|
| Placebos | 1 | 2008 | 1668 | 0.010 |
Why?
|
| Photography | 1 | 1987 | 537 | 0.010 |
Why?
|
| Peptic Ulcer | 1 | 2005 | 222 | 0.010 |
Why?
|
| Genotype | 2 | 2008 | 13047 | 0.010 |
Why?
|
| Gastroscopy | 1 | 2005 | 213 | 0.010 |
Why?
|
| Goblet Cells | 1 | 2006 | 300 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1998 | 4984 | 0.010 |
Why?
|
| Arthroscopy | 1 | 1990 | 971 | 0.010 |
Why?
|
| Catheterization | 1 | 2008 | 1431 | 0.010 |
Why?
|
| Chest Pain | 1 | 2010 | 1099 | 0.010 |
Why?
|
| Neoplasms | 2 | 2008 | 22386 | 0.010 |
Why?
|
| Safety | 1 | 2007 | 1159 | 0.010 |
Why?
|
| Models, Statistical | 2 | 1995 | 5103 | 0.010 |
Why?
|
| Reference Values | 1 | 1990 | 4941 | 0.010 |
Why?
|
| Coronary Disease | 2 | 1999 | 5926 | 0.010 |
Why?
|
| Haplotypes | 1 | 2008 | 2725 | 0.010 |
Why?
|
| Oxygen Consumption | 2 | 1999 | 1882 | 0.010 |
Why?
|
| Duodenoscopy | 1 | 2002 | 45 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2008 | 8201 | 0.010 |
Why?
|
| Cytokines | 1 | 2017 | 7449 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1987 | 1670 | 0.010 |
Why?
|
| Hepatitis B virus | 1 | 1985 | 530 | 0.010 |
Why?
|
| Carrier State | 1 | 1985 | 529 | 0.010 |
Why?
|
| Bile Duct Diseases | 1 | 2002 | 98 | 0.010 |
Why?
|
| Prosthesis Failure | 1 | 1987 | 1208 | 0.010 |
Why?
|
| Thermal Conductivity | 2 | 1994 | 16 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2008 | 2925 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1989 | 2206 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3816 | 0.010 |
Why?
|
| Random Allocation | 2 | 1996 | 2399 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2009 | 3637 | 0.010 |
Why?
|
| Receptor, IGF Type 2 | 1 | 2000 | 35 | 0.010 |
Why?
|
| Mathematics | 2 | 1995 | 704 | 0.010 |
Why?
|
| Deglutition Disorders | 1 | 2006 | 637 | 0.010 |
Why?
|
| Microcirculation | 2 | 1996 | 1282 | 0.010 |
Why?
|
| Patient Selection | 1 | 2012 | 4266 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2013 | 5995 | 0.010 |
Why?
|
| Reoperation | 1 | 2010 | 4342 | 0.010 |
Why?
|
| Lung Diseases | 1 | 1989 | 1926 | 0.010 |
Why?
|
| Child | 4 | 2011 | 80863 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1988 | 2422 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 15460 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2000 | 282 | 0.010 |
Why?
|
| Hyperventilation | 1 | 1999 | 78 | 0.010 |
Why?
|
| Glaucoma | 1 | 1989 | 1193 | 0.010 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2000 | 306 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 1991 | 4052 | 0.010 |
Why?
|
| Anaerobiosis | 1 | 1998 | 140 | 0.010 |
Why?
|
| Partial Pressure | 1 | 1998 | 247 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 6091 | 0.010 |
Why?
|
| Muscle Fatigue | 1 | 1999 | 96 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 6320 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 2000 | 393 | 0.010 |
Why?
|
| Cholesterol | 1 | 1987 | 2910 | 0.010 |
Why?
|
| Heart Failure | 2 | 1999 | 11857 | 0.010 |
Why?
|
| Fluoroscopy | 1 | 2002 | 952 | 0.010 |
Why?
|
| DNA Repair | 1 | 2007 | 2051 | 0.010 |
Why?
|
| Blood Volume | 1 | 1999 | 546 | 0.010 |
Why?
|
| Least-Squares Analysis | 1 | 1998 | 368 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1988 | 3458 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1989 | 2816 | 0.010 |
Why?
|
| Synovitis | 1 | 1998 | 217 | 0.010 |
Why?
|
| Life Expectancy | 1 | 2003 | 1249 | 0.010 |
Why?
|
| Ovalbumin | 1 | 1998 | 678 | 0.010 |
Why?
|
| Radiography | 1 | 2007 | 6995 | 0.010 |
Why?
|
| Drug Costs | 1 | 2004 | 1196 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1996 | 292 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1999 | 1502 | 0.010 |
Why?
|
| Body Water | 1 | 1996 | 340 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2006 | 4526 | 0.010 |
Why?
|
| Tissue Adhesions | 1 | 1996 | 223 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 1989 | 2444 | 0.010 |
Why?
|
| Surface Properties | 1 | 1998 | 1168 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1994 | 398 | 0.010 |
Why?
|
| Sex Distribution | 1 | 1999 | 2286 | 0.010 |
Why?
|
| Energy Transfer | 1 | 1994 | 109 | 0.010 |
Why?
|
| Phenylephrine | 1 | 1994 | 294 | 0.010 |
Why?
|
| Physical Fitness | 1 | 1998 | 744 | 0.010 |
Why?
|
| Hindlimb | 1 | 1996 | 516 | 0.010 |
Why?
|
| Age Distribution | 1 | 1999 | 2881 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1998 | 2126 | 0.010 |
Why?
|
| Sympathetic Nervous System | 1 | 1996 | 521 | 0.010 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 1999 | 843 | 0.010 |
Why?
|
| Decision Making | 1 | 2006 | 3961 | 0.010 |
Why?
|
| Flavin-Adenine Dinucleotide | 1 | 1992 | 31 | 0.010 |
Why?
|
| Sheep | 1 | 1995 | 1451 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2009 | 26351 | 0.010 |
Why?
|
| Perfusion | 1 | 1996 | 1402 | 0.010 |
Why?
|
| Dyspnea | 1 | 1999 | 1352 | 0.010 |
Why?
|
| Arthroscopes | 1 | 1990 | 11 | 0.010 |
Why?
|
| Body Temperature | 1 | 1994 | 781 | 0.010 |
Why?
|
| Exercise Test | 1 | 1998 | 2186 | 0.010 |
Why?
|
| Data Collection | 1 | 1999 | 3329 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1994 | 2488 | 0.010 |
Why?
|
| Pregnancy | 1 | 2012 | 30179 | 0.010 |
Why?
|
| Biology | 1 | 1992 | 291 | 0.010 |
Why?
|
| Neodymium | 1 | 1989 | 20 | 0.010 |
Why?
|
| Infant | 1 | 2011 | 36497 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1998 | 6242 | 0.010 |
Why?
|
| Knee Joint | 1 | 1998 | 1683 | 0.010 |
Why?
|
| Anesthesia, General | 1 | 1996 | 1185 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2011 | 42623 | 0.000 |
Why?
|
| Immune Sera | 1 | 1989 | 605 | 0.000 |
Why?
|
| Kidney | 1 | 2004 | 7064 | 0.000 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2000 | 4534 | 0.000 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 1998 | 2145 | 0.000 |
Why?
|
| Pattern Recognition, Automated | 1 | 1992 | 998 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 13708 | 0.000 |
Why?
|
| Diffusion | 1 | 1987 | 818 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1994 | 4202 | 0.000 |
Why?
|
| United States | 1 | 2012 | 73121 | 0.000 |
Why?
|
| Atrophy | 1 | 1989 | 1648 | 0.000 |
Why?
|
| Collagen | 1 | 1992 | 2646 | 0.000 |
Why?
|
| Models, Anatomic | 1 | 1987 | 684 | 0.000 |
Why?
|
| Intraocular Pressure | 1 | 1989 | 1304 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 15638 | 0.000 |
Why?
|
| Radiometry | 1 | 1987 | 816 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1989 | 19041 | 0.000 |
Why?
|